English | Español

Bristol-Myers Squibb
Jamie Barrand | Feb 23, 2016

Bristol-Myers Squibb's hepatitis C study focuses on Asian populations
Jamie Barrand | Feb 18, 2016

Pharmaceutical partnership to focus on high-risk cancer research
Jamie Barrand | Feb 10, 2016

FDA expands label for Bristol-Myers Squibb's Daklinza therapy
Jamie Barrand | Feb 4, 2016

Pharmaceutical companies investigate anticoagulant agent to reduce strokes
Caitlin Nordahl | Jan 29, 2016

FDA expands approved use of Bristol-Myers Squibb’s late-stage melanoma treatment
Kasey Schefflin- Emrich | Jan 26, 2016

Bristol-Myers Squibb recognized for advancing multiple myeloma research
Jamie Barrand | Jan 2, 2016

Bristol-Myers Squibb sells HIV therapy portfolio to ViiV Healthcare
Jamie Barrand | Jan 2, 2016

Bristol-Myers Squibb gives $397,422 to help launch military transition project

Trending
+ Pharmaceuticals
Patient Daily | Jun 2, 2025

PathAI collaborates with Northwestern Medicine on digital pathology advancements
+ Pharmaceuticals
Patient Daily | May 28, 2025

University of California medical researcher: ‘The 340B program is not associated with an improvement in mortality for low-income patients'
+ Pharmaceuticals
Patient Daily | May 29, 2025

Executive director of COA on 340B reform: ‘Start with PBMs then mega hospitals that pocket 340B discounts’
+ Regulatory
Patient Daily | May 30, 2025

Alliance for Pharmacy Compounding calls for eliminating redundant, unauthorized, or ineffective regulation